Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase

Y Kubota1, T Tanaka, A Kitanaka

  • 1Department of Transfusion Medicine, School of Medicine and Environmental Health Sciences, Kagawa Medical University, Kagawa 761-0793, Japan. ketsuken@kms.ac.jp

The EMBO Journal
|October 13, 2001
PubMed

Insights

Src kinase regulates erythroid differentiation by controlling phosphatidylinositol 3-kinase (PI3-kinase) activity. This study reveals how erythropoietin signaling involves Src and PI3-kinase in cell differentiation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Hematopoiesis

Background:

  • Erythropoietin (EPO) is crucial for red blood cell production.
  • The molecular pathways of EPO-induced erythroid differentiation are complex.
  • Src and PI3-kinase are implicated in cellular signaling.

Purpose of the Study:

  • To elucidate the role of Src and PI3-kinase in EPO-initiated erythroid differentiation.
  • To investigate the interaction between Src, PI3-kinase, and the EPO receptor.

Main Methods:

  • Use of antisense oligonucleotides and specific inhibitors (LY294002, PP1).
  • Analysis of protein-protein interactions (Src-PI3-kinase, EPO receptor-PI3-kinase).
  • In vitro kinase assays and binding experiments.

Main Results:

  • Inhibition of Src or PI3-kinase blocked EPO-dependent colony formation and differentiation.
  • Src directly tyrosine-phosphorylated the EPO receptor and associated with PI3-kinase.
  • EPO-induced activation and association of PI3-kinase with the EPO receptor were dependent on Src.

Conclusions:

  • Src acts as a key mediator in EPO signal transduction.
  • Src regulates erythroid differentiation by modulating PI3-kinase activity.
  • This pathway is critical for EPO-driven hematopoiesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...